Financial reports
10-K
2023 FY
Annual report
1 Apr 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
10-K
2022 FY
Annual report
30 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
10-K
2021 FY
Annual report
28 Mar 22
10-Q
2021 Q3
Quarterly report
15 Nov 21
Current reports
8-K
BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwn
16 Apr 24
8-K
Other Events
11 Apr 24
8-K
BrainStorm Cell Therapeutics Announces Agreement with FDA on a
9 Apr 24
8-K
Entry into a Material Definitive Agreement
2 Apr 24
8-K
BrainStorm Cell Therapeutics Announces Full Year 2023 Financial Results and Provides Corporate Update
1 Apr 24
8-K
BrainStorm Issues 2023 Letter to Shareholders
20 Dec 23
8-K
BrainStorm Cell Therapeutics Announces In-Person Meeting with the FDA to Discuss Confirmatory Phase 3 Trial for NurOwn® in ALS
22 Nov 23
8-K
BrainStorm Cell Therapeutics Announces Third quarter 2023 Financial Results and Provides Corporate Update
14 Nov 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9 Nov 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
3 Nov 23
Registration and prospectus
424B5
Prospectus supplement for primary offering
2 Apr 24
424B5
Prospectus supplement for primary offering
19 Jul 23
S-8
Registration of securities for employees
10 Dec 21
S-3
Shelf registration
9 Aug 21
424B5
Prospectus supplement for primary offering
25 Sep 20
424B3
Prospectus supplement
10 Aug 20
424B3
Prospectus supplement
26 Jun 20
424B3
Prospectus supplement
26 Jun 20
424B5
Prospectus supplement for primary offering
6 Mar 20
424B5
Prospectus supplement for primary offering
6 Mar 20
Proxies
DEFA14A
Additional proxy soliciting materials
22 Nov 23
DEF 14A
Definitive proxy
8 Nov 23
DEF 14A
Definitive proxy
13 Dec 22
DEF 14A
Definitive proxy
4 Nov 21
DEF 14A
Definitive proxy
1 Oct 20
DEF 14A
Definitive proxy
25 Oct 19
DEF 14A
Definitive proxy
10 Oct 18
DEF 14A
Definitive proxy
14 Sep 17
DEF 14A
Definitive proxy
11 May 16
PRE 14A
Preliminary proxy
22 Apr 16
Other
EFFECT
Notice of effectiveness
20 Aug 21
CORRESP
Correspondence with SEC
17 Aug 21
UPLOAD
Letter from SEC
16 Aug 21
EFFECT
Notice of effectiveness
3 Sep 19
CORRESP
Correspondence with SEC
28 Aug 19
UPLOAD
Letter from SEC
22 Aug 19
EFFECT
Notice of effectiveness
28 Sep 18
CORRESP
Correspondence with SEC
21 Sep 18
UPLOAD
Letter from SEC
6 Jul 18
EFFECT
Notice of effectiveness
2 Jul 18